Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Prevalence of large granular lymphocytosis in patients with chronic myelogenous leukemia (CML) treated with dasatinib.

× No keyword cloud information.

7 in total

1. Rapid and sustained increase of large granular lymphocytes and rare cytomegalovirus reactivation during dasatinib treatment in chronic myelogenous leukemia patients.

Authors: Hideo Tanaka; Shizuka Nakashima; Miyuki Usuda
Journal: Int J Hematol Date: 2012-07-06 Impact factor: 2.490

Review 2. Large granular lymphocytosis during dasatinib therapy.

Authors: Zhi-Yuan Qiu; Wei Xu; Jian-Yong Li
Journal: Cancer Biol Ther Date: 2013-12-18 Impact factor: 4.742

3. Relative increase in lymphocytes from as early as 1 month predicts improved response to dasatinib in chronic-phase chronic myelogenous leukemia.

Authors: Takashi Kumagai; Eri Matsuki; Koiti Inokuchi; Kazuteru Ohashi; Atsushi Shinagawa; Jin Takeuchi; Chikashi Yoshida; Shinichiro Okamoto; Hisashi Wakita; Yasuji Kozai; Yukari Shirasugi; Shin Fujisawa; Osamu Iwase; Shingo Yano; Kaichi Nishiwaki; Koji Oba; Junichi Sakamoto; Hisashi Sakamaki
Journal: Int J Hematol Date: 2013-12-03 Impact factor: 2.490

Prevalence of large granular lymphocytosis in patients with chronic myelogenous leukemia (CML) treated with dasatinib.

1. Rapid and sustained increase of large granular lymphocytes and rare cytomegalovirus reactivation during dasatinib treatment in chronic myelogenous leukemia patients.

Review 2. Large granular lymphocytosis during dasatinib therapy.

3. Relative increase in lymphocytes from as early as 1 month predicts improved response to dasatinib in chronic-phase chronic myelogenous leukemia.

4. Synergistic anti-tumor effects of dasatinib and dendritic cell vaccine on metastatic breast cancer in a mouse model.

Review 5. Persistent Large Granular Lymphocyte Clonal Expansions: "The Root of Many Evils"-And of Some Goodness.

6. Dasatinib promotes Th1-type responses in granzyme B expressing T-cells.

7. Lymphocytosis after treatment with dasatinib in chronic myeloid leukemia: Effects on response and toxicity.